Olema Pharmaceuticals, Inc. (OLMA)
10.27
-0.52
(-4.82%)
USD |
NASDAQ |
Aug 28, 16:00
10.27
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals 1 Year Total Returns (Daily) : 86.05% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | 86.05% |
| August 27, 2026 | 87.98% |
| August 26, 2026 | 89.35% |
| August 25, 2026 | 95.17% |
| August 24, 2026 | 81.08% |
| August 21, 2026 | 92.96% |
| August 20, 2026 | 100.0% |
| August 19, 2026 | 108.3% |
| August 18, 2026 | 84.90% |
| August 17, 2026 | 95.46% |
| August 14, 2026 | 102.1% |
| August 13, 2026 | 99.43% |
| August 12, 2026 | 96.61% |
| August 11, 2026 | 128.2% |
| August 10, 2026 | 157.3% |
| August 07, 2026 | 155.3% |
| August 06, 2026 | 136.9% |
| August 05, 2026 | 115.6% |
| August 04, 2026 | 117.4% |
| August 03, 2026 | 111.6% |
| July 31, 2026 | 122.8% |
| July 30, 2026 | 131.8% |
| July 29, 2026 | 123.4% |
| July 28, 2026 | 140.6% |
| July 27, 2026 | 155.0% |
| Date | Value |
|---|---|
| July 24, 2026 | 156.0% |
| July 23, 2026 | 151.9% |
| July 22, 2026 | 153.1% |
| July 21, 2026 | 152.5% |
| July 20, 2026 | 157.4% |
| July 17, 2026 | 154.3% |
| July 16, 2026 | 142.8% |
| July 15, 2026 | 157.5% |
| July 14, 2026 | 145.3% |
| July 13, 2026 | 154.8% |
| July 10, 2026 | 145.6% |
| July 09, 2026 | 146.1% |
| July 08, 2026 | 165.0% |
| July 07, 2026 | 183.8% |
| July 06, 2026 | 179.4% |
| July 02, 2026 | 178.4% |
| July 01, 2026 | 176.4% |
| June 30, 2026 | 193.7% |
| June 29, 2026 | 164.1% |
| June 26, 2026 | 149.8% |
| June 25, 2026 | 140.6% |
| June 24, 2026 | 137.5% |
| June 23, 2026 | 151.3% |
| June 22, 2026 | 142.1% |
| June 18, 2026 | 132.0% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 10.98% |
| Alnylam Pharmaceuticals, Inc. | -47.58% |
| Anika Therapeutics, Inc. | 128.6% |
| Savara, Inc. | 60.86% |
| Vericel Corp. | 14.10% |